Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_896_Библиотеки_им_академика_М_И_Перельмана
.pdf
26 The Charcot Foot inDiabetes
https://t.me/med1917
481
processes are not yet rmly established, bisphosphonates
have been postulated as having a role in both syndromes for
different reasons. Bisphosphonates inhibit bone resorption
by osteoclasts in osteoporosis or in Charcot fractures with
mixed data in response to bisphosphonate therapy [39–45].
Jeffcoate has also suggested that a dysregulation of the
RANK-L (receptor activator of nuclear factor kappa B
ligand)/OPG (osteoprotegerin) signaling pathway resulting
from a disproportionate release of pro-inammatory and
anti-inammatory cytokines and attendant effects on blood
ow and bone turnover might also play a role in this regard
[3, 46–48]. Inammation stimulates osteoclastogenesis combined with mechanical force through gait on the neuropathic
foot, ultimately disrupting the pedal architecture. Further
study is required, however, to determine how these pathways
interact in patients with neuropathy to cause increased vascularity and subsequent osteopenia.
Clinical Presentation
The classic presentation for the active Charcot foot includes
several characteristic clinical ndings which are summarized
in Table26.1. Typically, the patient with a Charcot foot will
have had a long duration of diabetes, usually in excess of
12years. Although all age groups can be affected, a review
of the literature in this regard indicates that the majority of
patients are in their sixth decade (mid-50s) [28, 49]. A more
recent report, however, indicates that there is an apparent age
difference in onset of patients with type 1 and type 2 diabetes
[50]. Whereas the average age at presentation for the entire
cohort and type 2 diabetes patients is indeed in the sixth
decade, for type 1 diabetes patients, the age at onset was in
the fth decade (40s). Patients with type 1 diabetes also demonstrated a longer duration of the disease than in type 2 diabetes patients with osteoarthropathy (24 vs. 13years) [50].
This has also been corroborated by an earlier report from
Finland [51]. While unilateral involvement is the most frequent presentation, bilateral Charcot foot can be found in
9–18% of patients [7, 17], although in the author’s experience, rarely does active Charcot foot present bilaterally.
The initial presentation for active Charcot arthropathy is
usually quite distinct in that a patient will seek attention for
a profoundly swollen foot that is difcult to t into a shoe
(Fig. 26.3). Although classically described as painless,
75% of these patients will complain of pain or aching in an
otherwise insensate foot [17]. Frequently, an antecedent
history of some type of injury can be elicited from the
patient [34]. When no such history is available, the precipitating event might simply have gone unrecognized in the
neuropathic limb.
On examination, the pulses will be characteristically
bounding even through the grossly edematous foot [28, 52].
Occasionally, however, the swelling will obscure one or both
pedal pulses. In concert with the hyperemic response to
Table 26.1 Clinical features of an acute are or active Charcot foot
Osseous Vascular Nerve Integument
Rocker-bottom
deformity
Subluxation of
the midfoot or
hindfoot
Digital
subluxation
Rearfoot
equinovarus
Ankle varus Light touch
Joint crepitus Anhidrosis
Joint
hypermobility
Increased or
bounding
pedal pulses
Erythema Pain Hyperkeratosis
Edema Absent or poor
Calor Decreased or
Absent or
diminished
protective
sensation
vibratory
testing
absent deep
tendon reexes
sensation
diminished
Neuropathic
pressure ulcer
Infection
Gangrene
Xerosis
Fig. 26.3 Acute Charcot ankle with profound foot and leg edema

482
https://t.me/med1917
L. C. Rogers et al.
injury, the foot will also be somewhat erythematous and
warmer or hot in relation to the contralateral foot. The skin
temperature elevation can be ascertained by dermal infrared
thermometry or thermography and will contrast with the
unaffected side by 3–8°C (Fig.26.4) [17, 49, 51, 53–58].
There is always some degree of sensory neuropathy in which
reexes, vibratory sense, proprioception, light touch, and
pain (pin prick) are diminished or absent. Motor neuropathy
can present as a foot drop deformity or intrinsic muscle atrophy. Ankle equinus can sometimes be ascertained initially
but may be difcult to perceive if there is gross osseous
deformity and laxity in the midfoot. Clinical exam is paramount to determine if equinus is present secondary to
Achilles contracture or osseous bony block at the ankle.
Autonomic neuropathy, which coexists with somatosensory
neuropathy in diabetes, can be clinically appreciated by the
presence of anhidrosis with very dry skin and/or callus formation or by measuring heart rate variability with deep
breathing [25, 26]. Although more common in the chronic or
inactive Charcot foot, plantar ulceration might be evident on
initial presentation. A concomitant ulceration will therefore
raise questions of potential contiguous soft tissue infection
or suspicion of osteomyelitis [28, 33, 52].
The skeletal changes frequently manifest as obvious
deformity of the midfoot with collapse of the arch and/or
rocker-bottom deformity (Fig.26.5) [33, 49]. Midfoot collapse can be attributed to the medial or lateral foot (or both)
and is a prognostic factor in healing, recurrence, and severity
a
Fig. 26.4 Thermograph of the plantar feet with signicant temperature
difference, indicating active midfoot Charcot process of the right foot
b
Fig. 26.5 (a) Clinical image of a chronic lateral midfoot ulcer associ-
ated with a rocker-bottom deformity. (b) Radiograph of same patient
showing severe rearfoot equinus with absence of heel purchase, negative calcaneal inclination angle, and midfoot arthropathy with
deformity

26 The Charcot Foot inDiabetes
https://t.me/med1917
of deformity [51, 52]. Associated ndings might often
include hypermobility with crepitus, signicant instability,
and ankle deformity.
Diagnosis ofActive Charcot Foot
The diagnosis of active Charcot foot is primarily based on
history and clinical ndings. Standard radiographs should
always be performed. Weight-bearing X-rays are most helpful in evaluating subluxations and angular deformities.
Contralateral X-rays (or previous X-rays) for comparison
might make subtle subluxations more evident. Advanced
imaging can help conrm diagnosis in complicated scenarios
or when the index of suspicion for the disorder is high in the
presence of an ostensibly normal X-ray. Inammation plays
a key role in the pathophysiology and is the earliest exam
nding [53, 59]. When presented with a warm, swollen,
insensate foot, plain radiographs are invaluable in ascertaining the presence of osteoarthropathy and the degree [28, 60].
In most cases, no further imaging studies will be required to
make the correct diagnosis. However, in the active, prodromal “stage 0” of Charcot foot, there may be primarily soft
tissue changes noted without X-ray evidence of distinct bone
or joint pathology [61, 62]. Further investigation with MRI,
serial radiographs, or scintigraphy should be considered
when suspicion is high for osteoarthropathy or concomitant
wound to investigate for osteomyelitis [63–67]. Admittedly,
differentiating between acute Charcot arthropathy, acute
gout, and osteomyelitis solely based on plain radiographs
can be difcult [68]. Additional laboratory studies may prove
useful in determining the appropriate diagnosis. Leukocytosis
can often suggest acute osteomyelitis; however, this normal
response to infection can be blunted in persons with diabetes
or autoimmune disorders [68, 69]. While the erythrocyte
sedimentation rate (ESR) may also be elevated in the case of
gout or acute infection, it often responds similarly to any
inammatory process and is therefore nonspecic. Similarly,
C-reactive protein (CRP) is an inammatory marker but rises
in hours and thus can be trended in an acute window directly
monitoring for inammation or infection and can be utilized
to monitor therapy response as it is often elevated for only
3–7days [70]. Neither lab tests have been determined to be
superior and are likely to yield concordant results [70].
Comparably, procalcitonin is a biologic serum marker also
detectable within hours and peaks earlier than ESR and CRP,
within 1day, and is not elevated in noninfectious inammatory conditions. Procalcitonin can be helpful in trending bacterial infections or sepsis and in a systematic review was
noted to be more sensitive, more specic, and more accurate
in differentiating inammation due to infection versus non-
483
Fig. 26.6 Light micrograph of a pathology slide of the bone from an
active neuroarthropathic foot (100×, decalcied, H&E stain). Note the
center trabeculum has incongruous edges with osteoclasts (solid arrow),
many inammatory cells, and trabecular fragmentation (broken arrows)
infectious cases and furthermore differentiating bacterial
versus viral causes [71, 72]. All three inammatory markers
can predict severity of infection and anticipated hospital
duration [71–74].
When a foot ulcer probes to the bone, a bone biopsy is
recommended to formally diagnose osteomyelitis [28, 75,
76]. A biopsy consisting of multiple shards of bone and soft
tissue embedded in the deep layers of synovium is pathognomonic for neuroarthropathy (Fig.26.6) [77].
Radiographic Imaging
Radiographically, osteoarthropathy takes on the appearance of
a severely destructive form of degenerative arthritis. Serial
radiographs customarily demonstrate changes occurring
throughout the process and can assist in monitoring disease
activity [75]. Occasionally, nucleotide scanning, CT, or MRI
may be necessary to establish the diagnosis. The acute or developmental stage is marked by an abundance of soft tissue edema,
osteopenia, multiple fractures, loose bodies, subluxation, or
dislocation [33, 78–80]. These radiographic ndings are fairly
typical of noninfective bone changes associated with diabetes
and have been described well by Newman [81]. In addition to
alterations in the normal pedal architecture, the metatarsal
heads and phalanges can demonstrate atrophic changes referred
to as diabetic osteolysis. Synonyms for this phenomenon
include a “sucked candy” appearance, “pencil pointing,” “hourglass” deformities of the phalanges, or “mortar and pestle”
deformity of the metatarsophalangeal joints [81, 82]. Massive
osteolysis can also occur in the rearfoot during the acute stage,
especially in the ankle and subtalar joints (Fig.26.7).

484
bd
https://t.me/med1917
L. C. Rogers et al.
Fig. 26.7 (a–d) Osteolysis of
the talus with disintegration
of the ankle, subtalar, and
calcaneal-cuboid joints.
Distention of the hindfoot
joints lled with synovial
uid and dissolved
periarticular structures
a
c
These changes will often coexist with the obvious fractures initiated by the destructive process. Another associated
nding in Charcot arthropathy is medial arterial calcication
(Fig.26.8) [25].
Chronic reparative or quiescent radiographic changes
include hypertrophic changes such as new periosteal bone
formation, coalescence of fractures and bony fragments,
sclerosis, remineralization, and reduction in soft tissue
edema [28, 49, 83]. Rocker-bottom deformities, calcaneal
equinus, dropped or negative cuboid, or other deformities not
previously appreciated may also become visible, especially
in weight-bearing images. Lateral weight-bearing foot
radiographs are invaluable since they show two important
bearing foot X-ray) should be unbroken (Fig. 26.9).
Table26.2 summarizes the varieties of radiographic changes
found in neuroarthropathy.
Sanders and Frykberg described radiographic patterns of
joint involvement based upon joint location [49]. These patterns may exist independently or in combination with each
other as determined through clinical and radiographic ndings. They are illustrated in Fig.26.10 and described as follows: Pattern I, forefoot-metatarsal-phalangeal joints; Pattern
II, tarsometatarsal (Lisfranc’s) joint; Pattern III, midtarsal
and navicular-cuneiform joints; Pattern IV, ankle and subtalar joints; and Pattern V, calcaneus (calcaneal insufciency
avulsion fracture) [32, 33, 49].
radiographic features of Charcot foot deformities, the calcaneal inclination angle and the talo-rst metatarsal relationship. The calcaneal inclination angle (normally 20°) is often
reduced or in severe deformity as a declination (negative
angle). The lateral talo-rst metatarsal relationship (a line
bisecting the talus and the rst metatarsal on lateral weight-
Pattern I: Forefoot
Pattern I encompasses atrophic changes or osteolysis of the
metatarsophalangeal and interphalangeal joints with the
characteristic sucked candy appearance of the distal metatarsals [52, 80]. Frequently, atrophic bone resorption of the dis-

26 The Charcot Foot inDiabetes
https://t.me/med1917
485
Fig. 26.9 Lateral weight-bearing radiographs of a patient before (top)
and after (below) the development of a rocker-bottom deformity with
midfoot collapse. The calcaneal inclination angle (white) has signicantly decreased, and the talo-rst metatarsal relationship (black) is
broken and abnormal
Fig. 26.8 Calcication of the vascular intima media or Monckeberg’s
sclerosis can be seen in many patients with Charcot foot and patients
with diabetes. In this lateral radiograph, the anterior tibial artery as it
transitions to the dorsalis pedis artery (solid arrow) and the posterior
tibial arteries are visible on plain radiograph due to vessel
calcications
tal metatarsals and phalanges accompanies other changes
found in the midfoot and rearfoot. An infectious etiology has
been proposed for these ndings although osteolysis can
occur without any prior history of joint sepsis. Reports of
10–30% of the neuroarthropathies have been categorized as
Pattern I [5, 17, 49, 66, 68, 82].
Pattern II: Tarsometatarsal (Lisfranc’s) Joint
Pattern II involves Lisfranc’s joint, typically with the earliest
clue being a very subtle lateral deviation of the base of the
second metatarsal at the cuneiform joint. Once the stability
of this “keystone” is lost, the Lisfranc’s joint complex will
often subluxate dorsolaterally. Fracture of the second metatarsal base allows for greater mobility in which subluxation
of the metatarsal bases will occur with appreciable diastasis
of the joint. The rupture of intermetatarsal and tarsometatarsal ligaments plantarly permits collapse of the arch during
normal weight-bearing, leading to the classic rocker-bottom
deformity. Compensatory contracture of the triceps surae
will frequently follow and create a further plantarexory
Table 26.2
Stage Atrophic changes
Active Osteolysis—
Inactive Distal metatarsal
Radiographic changes in neuroarthropathy
Hypertrophic
changes Miscellaneous
resorption of bone
Metatarsal heads,
phalangeal
diaphyses, MTP,
subtalar, ankle
Osteopenia
and rearfoot
osteolysis
Bone loss
Periosteal new
bone
Intra-articular
debris, joint mice,
fragments
Osteophytes,
architectural
collapse,
deformity
Periosteal new
bone
Marginal
osteophytes
Fracture bone
callus
Rocker bottom
Midfoot or ankle
deformity
Ankylosis
Joint effusions
Subluxations
Fractures
Soft tissue
edema
Medial arterial
calcication
Ulceration
Resorption of
debris
Diminished
edema
Sclerosis
Ulceration
moment to accentuate the inverted arch as compensation
decreases [84, 85]. This pattern also is commonly associated
with plantar ulcerations at the apex of the collapse, which
typically involves the cuboid or cuneiforms due to progressive midfoot collapse due to midfoot hypermobility and ligament attenuation, forefoot abduction, metatarsus primus

486
The High Risk Foot in Diabetes Mellitus
III.
https://t.me/med1917
L. C. Rogers et al.
I.
IPJ’s & Phalanges
MTPJ’s & Metatarsals
Ulceration
NC Joints
TN & CC Joints
II.
IV.
TMT Joints
Ulceration
Ankle Joints
V.
Calcaneus
KEY:
IPJ’s
MTPJ’s
TMT
NC
TN
CC
= Interphalangeal joint
= Metacarpophalangeal joint
= Tarsometatarsal
= Naviculocuneiform
= Talonavicular
= calcaneocuboid
Fig. 26.10 Patterns of diabetic osteoarthropathy can be classied based on anatomic involvement. (From Sanders LJ, Frykberg RG.The Charcot
foot. In: Frykberg RG, editor. The high-risk foot in diabetes mellitus. NewYork: Churchill Linvingston; 1991. p.325–35, with permission)

26 The Charcot Foot inDiabetes
https://t.me/med1917
487
varus, and hallux valgus (Chap. 11) [28, 49, 84–86]. This
was the most frequent pattern of presentation for diabetic
Charcot feet in the Sinha series and represents the most common presentation in clinical practice, with an occurrence of
40% [7, 80, 82].
Pattern III: Midtarsal and
Naviculocuneiform Joints
Pattern III incorporates changes within the midtarsal
(Chopart’s) joint being the talonavicular and calcaneocuboid
joints with the frequent addition of the naviculocuneiform
joint. As described by Newman and Lesko and Maurer, spontaneous dislocation of the talonavicular joint with or without
fragmentation characterizes this pattern [81, 87, 88].
Newman further suggested that isolated talonavicular
joint subluxation might even be considered as an entity separate from osteoarthropathy, although still an important element of noninfective neuropathic bone disease [81].
Lisfranc’s joint changes (Pattern II) are often seen in combination with Pattern III deformities of the lesser tarsus,
together contributing up to 70% of all pathologic patterns of
Charcot foot [80].
Pattern IV: Ankle andSubtalar Joint
Pattern IV involves the ankle joint, subtalar joint, and body
of the talus. Disintegration of the talar body is equivalent to
the central tarsal disintegration of Harris and Brand [88]. The
destructive forces are created by joint incongruity and continued mechanical stress which eventually erodes the talus
and periarticular surfaces. Massive osteolysis is frequently
observed in this pattern with attendant ankle or subtalar joint
subluxation and angular deformity, often with concomitant
ulceration. As noted, tibia or bular malleolar fractures are
frequently seen in association with neuroarthropathy in this
location and most likely precipitated by the development of
joint dissolution. Pattern IV Charcot is found in approximately 10% of reported cases [7, 49, 80].
Pattern V: Calcaneus (Calcaneal Insuciency
Avulsion Fracture)
Pattern V, the least common presentation (~2–5%), is characterized by extra-articular fractures of the calcaneus (posterior pillar) [2, 80]. This extra-articular fracture is included in
the neuropathic osteoarthropathy classication; however,
there is no joint involvement (Fig. 26.15). This is more
appropriately considered as a neuropathic fracture of the
body or, more commonly, the posterior tuberosity of the calcaneus. Kathol and El-Khoury [89, 90] have termed this
entity the “calcaneal insufciency avulsion fracture.”
Advanced Imaging
Technetium (Tc99) three-phase bone scans are exquisitely
sensitive for detecting Charcot arthropathy but are generally
nonspecic in assisting in the differentiation between osteomyelitis and acute neuroarthropathy [63, 91, 92]. Indium
(In111) scanning has been shown to be more specic for
infection; however, false-positive scans can be frequently
observed in rapidly evolving acute osteoarthropathy without
associated osteomyelitis [65, 92–94]. Additional studies
helpful in differentiating Charcot arthropathy from osteomyelitis include Tc-HMPAO labeled white blood cell scans and
magnetic resonance imaging [64, 91, 95, 96].
MRI examination can be very sensitive to the earliest
changes in neuroarthropathy but, again, is not reliable in
detecting bone infection superimposed upon the gross
changes noted surrounding a Charcot joint [64, 68, 91, 95,
96]. Morrison suggests the consideration of “secondary
signs” of osteomyelitis on MRI may help the clinician discern between Charcot foot and osteomyelitis [97].
Table 26.3 lists the secondary signs of Charcot foot and
osteomyelitis [97].
Another imaging modality that may show some promise
in this regard is positron emission tomography (PET) [98,
99]. Hopfner and colleagues reported that this modality
could not only detect early osteoarthropathy with 95% sensitivity but could also reliably distinguish between Charcot
arthropathy and osteomyelitis even in the presence of
implanted hardware [100]. However, no study is 100% accurate in distinguishing neuropathic bone lesions from infectious entities. Therefore, clinical acumen is necessary for
detecting Charcot arthropathy at its onset, and clinical judgment remains paramount in properly assessing and managing these patients. Rogers and Bevilacqua presented a
simplied algorithm based on imaging studies to help differentiate Charcot foot from osteomyelitis (Fig.26.11) [68].
The management can therefore be extrapolated based on risk
factors, level of injury, and level of instability [101].
Table 26.3 Comparing “secondary signs” of Charcot foot and osteomyelitis on magnetic resonance imaging (MRI)
Charcot foot Osteomyelitis
Characteristic No visible track to
bone
Primarily affects
midfoot
Multiple bones
involved
Deformity is
common
Visible track from skin to
bone
Primarily affect forefoot and
rearfoot
Usually only one bone
affected
Deformity is uncommon

488
https://t.me/med1917
Fig. 26.11 Standard imaging
studies to aid in
differentiating Charcot foot
from osteomyelitis. (From
Rogers LC, Bevilacqua
NJ.Imaging of the Charcot
foot. Clin Podiatr Med Surg.
2008;25(2):263–274, vii.,
with permission)
L. C. Rogers et al.
Clinical Suspicion
of Charcot Foot
Bone destruction
on x-ray?
99Tc
bone
scan
(–)
NO
CHARCOT
or OM
Classication ofCharcot Arthropathy
The Eichenholtz classication is one of the earliest classications for Charcot joints and is based on the radiographic
evidence of joint pathology. Eichenholtz divided osteoarthropathy into developmental, coalescence, and reconstructive stages [83]. Several other authors have subsequently
proposed an earlier “Stage 0” that corresponds to the initial
inammatory period following injury but prior to the development of any characteristic bony radiographic changes [61,
67, 102].
This prodromal period might be considered as “osteoarthropathy in situ” stage. The traditional developmental stage,
stage I, is characterized by fractures, debris formation, and
fragmentation of cartilage and subchondral bone. This is followed by capsular distension, ligamentous laxity, varying
degrees of subluxation, and marked soft tissue swelling.
Synovial biopsy at this time will show osseous and cartilaginous debris embedded in a thickened synovium, which is
pathognomonic for the disease [83]. The coalescence stage,
stage II, is marked by the absorption of much of the ne
debris, a reduction in soft tissue swelling, bone callus proliferation, and consolidation of fractures. Finally, the recon-
(+)
Ye s
CHARCOT
Open wound?
Ye s
No
CHARCOT
MRI,*
111 In, or
99mTc
HMPAO
(–)
(+)
OM or
Charcot +
OM
No
structive stage, stage III, is denoted by bony ankylosis and
hypertrophic proliferation with some restoration of stability.
In certain cases, however, severe osseous disintegration
occurs due to prolonged activity resulting in permanent
deformity of the foot and/or ankle. In these situations, the
condition may be referred to as chronically active, and little
healing, if any, takes place and is termed in remission [76].
While the system is radiologically very descriptive and useful, its practical clinical applicability is less so. In clinical
practice, the initial developmental stage is considered active
or acute, while the coalescent and reconstructive stages are
considered to be the inactive or quiescent stages. Other classication systems have been described based upon anatomic
sites of involvement but do not describe the activity of the
disease [61, 88, 103–105]. Rogers and Bevilacqua described
a prognostic staging system based on anatomic location and
complicating factors of the Charcot joint (Fig.26.12) [105,
106], which was later validated as prognostic for amputation
by Viswanathan etal. in a group of 53 patients [107]. The
Sanders and Frykberg classication is descriptive, based on
the site of involvement, and was described in detail above
[49]. None of the above detail absolute treatment intervention in regards to time or procedure.

Classifying Charcot Arthropahy
(more complicated)
pressure
(less contact
2
26 The Charcot Foot inDiabetes
https://t.me/med1917
489
(more proximal)
Location and
Stage
A. Acute
Charcot
without
deformity
B. Charcot
with
deformity
C. Charcot
with
deformity
and
ulceration
D. Charcot
with
osteomyelitis
Fig. 26.12 Rogers and Bevilacqua dual axis classication of Charcot
foot amputation risk based upon location and complications
1. Forefoot 2. Midfoot
Low Risk of
Extremity
Amputation
3. Rearfoot/
Ankle
High Risk of
Extremity
Amputation
The American Diabetes Association and American Podiatric
Medical Association created the Joint Task Force on the
Charcot Foot comprised of a multinational group of Charcot
foot experts in 2010. Given the confusion about classications,
their limited prognostic value, and inability to direct treatment,
the Joint Task Force recommended simplifying the clinical
classication of the Charcot foot to active or inactive based on
the presence of inammation [59]. Subsequently, the
International Working Group on the Diabetic Foot (IWGDF)
provided updated guidelines on the diagnosis and treatment of
Charcot neuro-osteoarthropathy in 2023 [108].
tive impairment and increased risk of falls with ofoading
treatment. Since total non-weight-bearing is frequently
unattainable for many patients in this category, total contact
cast (TCC) may serve as a useful alternative and is the most
effective form of ofoading while bearing weight [109,
112]. TCC can be applied safely in those with Charcot foot
but should be changed frequently at rst since edema tends
to reduce greatly with immobilization and ofoading which
will lead to a poorly tting cast [59]. Fig.26.13 shows the
major mechanisms of action of a total contact cast in relieving plantar pressure and immobilizing the foot and ankle. A
TCC is effective at reducing plantar pressures by approximately 30% [110, 111]. In those patients where a TCC cannot be used, a soft compressive dressing or Unna’s boot in
concert with a removable cast walker or pneumatic walking
brace can also be used secondarily in this regard [33].
However, a large study in the UK found that patients using
removable devices took signicantly longer to heal versus
the TCC group [20]. In the presence of ulcers or infections,
frequent debridement and careful observation are required.
Charcot neuropathic osteoarthropathy can take weeks to
months to reach remission, and ofoading with immobilization should be anticipated for approximately 6months or
more, depending on the severity of joint destruction [113].
Conversion to the inactive/reparative phase is heralded by a
reduction in pedal temperature to within 4°F (2.5 °C) of
that of the unaffected side and a sustained reduction in
edema [17].
Medical Management
Ooading
Immobilization and reduction of stress are considered the
most important initial treatment for active Charcot arthropathy [28, 59, 109–111]. Effective ofoading or complete
non- weight- bearing on the affected limb removes the continual trauma and should promote conversion of the active
Charcot joint to the inactive quiescent phase [28, 51, 78].
Non- weight- bearing is an accepted form of ofoading for
most foot and ankle injuries; however, three point crutch
gait may increase pressure to the contralateral limb, thereby
predisposing it to repetitive stress and ulceration or an active
Charcot episode [87]. Additionally, those with diabetic neuropathy tend to be older and overweight and do not have the
cardiovascular reserve for the additional energy required to
use crutches effectively. A patient with neuropathy severe
enough to lead to a Charcot foot will also have propriocep-
Shape
of the
leg
Eliminated
3
ankle
motion
Reduced
plantar
Fig. 26.13 An image of a total contact cast (TCC) depicting the major
mechanisms of action in ofoading and immobilization
Transferred
1
weight to the
4
5
tibia
Shortened
stride length
time on the
ground)
Fewer steps
per day

490
https://t.me/med1917
This should be corroborated with serial radiographs indicating consolidation of osseous debris, union of fractures, a
reduction in soft tissue edema, and no progression of deformity. McGill etal. have found a reduction in skin temperature and bone scan activity that mirrors activity of Charcot
neuroarthropathy, both of which improve as the condition
achieves the inactive stage or quiescence [54].
When the patient enters the inactive stage, management is
directed at a gradual resumption of weight-bearing with prolonged or permanent bracing [17, 28, 59]. Care must be
taken to gradually titrate the patient from non-weight- bearing
(or TCC) to partial to full weight-bearing with the use of
assistive devices (i.e., crutches, cane, or walker). Progression
to protected weight-bearing is permitted, usually with the aid
of some type of ambulatory, immobilizing device [112].
Charcot restraint orthotic walkers (CROW) or other similar
total contact prosthetic walkers have gained acceptance as
useful protective modalities for the initial period of weightbearing after TCC or surgical reconstruction [114]. These
custom-made braces usually incorporate some degree of
patellar tendon bearing as well as a custom footbed with a
rocker sole. A more readily available option is a pneumatic
walking brace or similar removable cast walker that might
incorporate a cushioned footbed or insole. These can be
made less removable or nonremovable by simply applying
adhesive tape or cast bandaging around the body of the brace
to help encourage compliance (Fig.26.14) [115, 116].
The mean time of rest and immobilization (casting followed by removable cast walker) prior to return to permanent protective footwear is approximately 4–12months [17,
20, 51]. Feet must be closely monitored during the time of
transition to permanent footwear to insure that the acute
inammatory process does not recur. Forefoot and midfoot
deformities often do well with custom full-length inserts and
comfort or extra-depth shoes once bracing is no longer
required [28].
Continuing effective ofoading with non-custom bracing
or TCC often serves as interim footwear prior to obtaining
permanent custom-made footwear. Severe midfoot deformities will often require the fabrication of custom shoes to
accommodate the misshapen foot. Rearfoot neuroarthropathy with minimal deformity may require only a deep, wellcushioned shoe with a full-length orthotic device. For mildly
unstable ankles without severe deformity or joint dissolution, high-top custom shoes can sometimes provide adequate
stability against transverse plane rotational forces. The moderately unstable ankle will benet from an ankle foot orthosis (AFO) and a high-top therapeutic shoe. The severely
unstable or maligned rearfoot will require a patellar tendon
bearing (PTB) brace incorporated into a custom shoe [116,
117]. The PTB brace has reportedly decreased the rearfoot
mean peak forces by at least 32% [117].
L. C. Rogers et al.
Fig. 26.14 A removable cast walker (RCW) rendered “less removable” with an external layer of cohesive bandage. Alternatively, berglass has be used
Antiresorptive Therapy
In the setting of altered bone mineral density (BMD) in
patients with diabetes and neuropathy, there has been
interest in the adjunctive use of bisphosphonate therapy in
acute Charcot arthropathy [31, 39, 118, 119]. However,
further study has cast a negative shadow on their routine
use for Charcot foot [20], and it was not recommended by
the Joint Task Force [59]. These pyrophosphate analogs
are potent inhibitors of osteoclastic bone resorption and
are widely used in the treatment of osteoporosis, Paget’s
disease, and reex sympathetic dystrophy syndrome.
Although one uncontrolled study of six patients found signicant reductions in foot temperature and alkaline phosphatase levels as compared to baseline, its small size and
lack of a control group preclude making any meaningful
conclusions from the treatment [119]. A subsequent multi-
Соседние файлы в папке Библиотека им академика М.И. Перельмана
